Diabetes
| Insulin
Diabetes
Insulin
Use of a one-time loading dose of once-weekly insulin efsitora alfa in phase 2 reduces transient hyperglycaemia and is not associated with excess hypoglycaemia risk vs degludec
book_2
Source:
EASD 2023 - Short Oral Session
calendar_today
Published on Medfyle:
October 2023
In this medfyle
Efsitora alfa loading dose strategy is safe and reduces transient hyperglycaemia
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of a presentation given at the EASD 2023 Annual Meeting. The content is developed by Infomedica in collaboration with the Diabetes Education Study Group (DESG).
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, Medfyle, or the DESG.
©2023 Infomedica-Medfyle. All rights reserved.
